It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer.
Thompson
Ian M
IM
Ankerst
Donna P
DP
Etzioni
Ruth
R
Wang
Thomas
T
D001707:Biopsy, Needle; D003657:Decision Making; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood / Q000592:standards*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000401:mortality / Q000473:pathology*; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D014481:United States
D017430:Prostate-Specific Antigen